ATE360696T1 - Interferon-ähnliches protein zcyto21 - Google Patents

Interferon-ähnliches protein zcyto21

Info

Publication number
ATE360696T1
ATE360696T1 AT01950827T AT01950827T ATE360696T1 AT E360696 T1 ATE360696 T1 AT E360696T1 AT 01950827 T AT01950827 T AT 01950827T AT 01950827 T AT01950827 T AT 01950827T AT E360696 T1 ATE360696 T1 AT E360696T1
Authority
AT
Austria
Prior art keywords
amino acid
zcyto21
interferon
acid sequence
genetically engineered
Prior art date
Application number
AT01950827T
Other languages
English (en)
Inventor
Paul O Sheppard
Scott R Presnell
Brian A Fox
Teresa Gilbert
Betty A Haldeman
Francis J Grant
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26910034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE360696(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE360696T1 publication Critical patent/ATE360696T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01950827T 2000-06-30 2001-06-29 Interferon-ähnliches protein zcyto21 ATE360696T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21544600P 2000-06-30 2000-06-30
US28542401P 2001-04-20 2001-04-20

Publications (1)

Publication Number Publication Date
ATE360696T1 true ATE360696T1 (de) 2007-05-15

Family

ID=26910034

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01950827T ATE360696T1 (de) 2000-06-30 2001-06-29 Interferon-ähnliches protein zcyto21
AT06012489T ATE404670T1 (de) 2000-06-30 2001-06-29 Allelische variante des interferon-ähnlichen proteins zcyto21

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06012489T ATE404670T1 (de) 2000-06-30 2001-06-29 Allelische variante des interferon-ähnlichen proteins zcyto21

Country Status (13)

Country Link
US (18) US6927040B2 (de)
EP (4) EP1717316B1 (de)
JP (1) JP4377126B2 (de)
CN (1) CN100448993C (de)
AT (2) ATE360696T1 (de)
AU (1) AU2001271786A1 (de)
BR (1) BR0112119A (de)
CA (1) CA2413258C (de)
DE (2) DE60135393D1 (de)
DK (2) DK1294888T3 (de)
ES (2) ES2286128T3 (de)
RU (1) RU2292394C2 (de)
WO (1) WO2002002627A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286128T3 (es) 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.
US7910313B2 (en) * 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US20030104579A1 (en) * 2001-05-10 2003-06-05 Baum Peter R. Cytokine polypeptides
US6902930B2 (en) * 2001-08-29 2005-06-07 Vanderbilt University Human Mob-5 (IL-24) receptors and uses thereof
AU2003215136A1 (en) 2002-02-08 2003-09-02 University Of Medicine And Dentistry Of New Jersey Ifn-a/b-independent mechanism of antiviral protection
ES2356307T3 (es) 2002-04-19 2011-04-06 Zymogenetics, L.L.C. Procedimientos para detectar o modular la interacción de un receptor de citocina con su ligando.
KR20050065519A (ko) * 2002-08-07 2005-06-29 델타 바이오테크놀로지 리미티드 알부민-융합 섬모 신경영양 인자
JP2006509041A (ja) * 2002-10-23 2006-03-16 ザイモジェネティクス，インコーポレイティド Ｉｌ−２８およびｉｌ−２９を用いるウイルス感染を治療するための方法
ES2303132T3 (es) 2003-08-07 2008-08-01 Zymogenetics, Inc. Preparaciones homogeneas de il-29.
EP1750749A2 (de) * 2004-04-02 2007-02-14 ZymoGenetics, Inc. Il-28 und il-29-cystein-mutanten zur behandlung von virusinfektion
RU2389502C2 (ru) * 2004-07-29 2010-05-20 Займодженетикс, Инк. Применение il-28 и il-29 для лечения карциномы и аутоиммунных нарушений
EP1793845A2 (de) * 2004-07-29 2007-06-13 ZymoGenetics, Inc. Verwendung von il-28 und il-29 zur krebsbehandlung
US20060178301A1 (en) * 2005-02-04 2006-08-10 Mathias Jurs Albumin-fused ciliary neurotrophic factor
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
JP2009502803A (ja) * 2005-07-20 2009-01-29 ザイモジェネティクス， インコーポレイテッド Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法
ATE491722T1 (de) 2005-10-04 2011-01-15 Zymogenetics L L C Herstellung und reinigung von il-29
TW200744634A (en) * 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
EP2217268B1 (de) 2007-12-07 2016-05-04 ZymoGenetics, Inc. Monoklonale antii-human-il-21-antikörper
CA2720168C (en) 2008-04-04 2024-04-30 David B. Weiner Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
EP2296691A1 (de) * 2008-06-05 2011-03-23 ZymoGenetics, L.L.C. Verwendung von pegylierten typ iii-interferonen zur behandlung von hepatitis c
US20110263484A1 (en) * 2008-10-13 2011-10-27 Zymogenetics, Inc. Single chain fc type iii interferons and methods of using same
JP5673796B2 (ja) 2010-04-28 2015-02-18 株式会社村田製作所 アニオン制御された誘電特性を有するペロブスカイト材料の製造方法、およびそれを用いた薄膜コンデンサ装置の製造方法
FR2975185A1 (fr) * 2011-05-12 2012-11-16 Univ Claude Bernard Lyon Procede de determination in vitro de la presence d'une sclerose en plaques
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
CN102998450B (zh) * 2012-11-22 2014-10-15 北京正旦国际科技有限责任公司 一种食管癌免疫质谱检测试剂盒的制备方法
EP3954714A1 (de) 2014-01-08 2022-02-16 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusionspolypeptide und verfahren zur verwendung
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
DK3285768T3 (da) 2015-04-21 2021-01-25 Eiger Biopharmaceuticals Inc Farmaceutiske sammensætninger omfattende lonafarnib og ritonavir
RS61944B1 (sr) 2016-02-19 2021-07-30 Eiger Biopharmaceuticals Inc Lečenje infekcije hepatitis delta virusom sa interferonom lambda
WO2018064574A1 (en) * 2016-09-30 2018-04-05 The Board Of Trustees Of The Leland Stanford Junior University Variant type iii interferons and synthekines

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000213A1 (de) 1980-01-04 1981-07-09 Zahnfabrik Wienand Söhne & Co GmbH, 6072 Dreieich Verfahren zur herstellung eines vernetzten polymerisatz fuer dentalzwecke
CY1346A (en) 1980-01-08 1987-01-16 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
DK368882A (da) 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4496778A (en) * 1983-10-03 1985-01-29 Exxon Research & Engineering Co. Process for the hydroxylation of olefins using molecular oxygen, an osmium containing catalyst, a copper Co-catalyst, and an aromatic amine based promoter
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4990446A (en) 1984-12-06 1991-02-05 Labofina, S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and use thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5700638A (en) * 1993-08-26 1997-12-23 Washington University Cell death regulator
US6451578B1 (en) * 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
HUT75359A (en) 1994-02-14 1997-05-28 Univ Washington Hematopoietic protein and materials and methods for making it
US5641655A (en) 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
US5679715A (en) * 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
US5716808A (en) 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US6025539A (en) * 1996-04-09 2000-02-15 Mayo Foundation For Medical Education And Research IL-5 transgenic mouse
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
CA2260293A1 (en) * 1996-07-09 1998-01-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5854039A (en) 1996-07-17 1998-12-29 Zymogenetics, Inc. Transformation of pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US5985614A (en) 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
JP4215172B2 (ja) 1996-12-03 2009-01-28 アムジェン フレモント インク． 複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
GB9702944D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Reducing fibrosis
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
AU2871899A (en) 1998-03-09 1999-09-27 Schering Corporation Human receptor proteins; related reagents and methods
WO1999054458A1 (en) * 1998-04-17 1999-10-28 Whitehead Institute For Biomedical Research Use of a ribozyme to join nucleic acids and peptides
EP1140143A2 (de) * 1998-12-18 2001-10-10 Schering Corporation Ribavirin-peg-interferon alpha induktions hcv kombinationstherapie
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
ES2286128T3 (es) 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US20030104579A1 (en) 2001-05-10 2003-06-05 Baum Peter R. Cytokine polypeptides
JP3939160B2 (ja) * 2001-05-25 2007-07-04 独立行政法人科学技術振興機構 腎臓における外来遺伝子発現方法
AU2003215136A1 (en) 2002-02-08 2003-09-02 University Of Medicine And Dentistry Of New Jersey Ifn-a/b-independent mechanism of antiviral protection
JP2006509041A (ja) 2002-10-23 2006-03-16 ザイモジェネティクス，インコーポレイティド Ｉｌ−２８およびｉｌ−２９を用いるウイルス感染を治療するための方法
ES2303132T3 (es) 2003-08-07 2008-08-01 Zymogenetics, Inc. Preparaciones homogeneas de il-29.
EP1750749A2 (de) 2004-04-02 2007-02-14 ZymoGenetics, Inc. Il-28 und il-29-cystein-mutanten zur behandlung von virusinfektion
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
EP2296691A1 (de) 2008-06-05 2011-03-23 ZymoGenetics, L.L.C. Verwendung von pegylierten typ iii-interferonen zur behandlung von hepatitis c
US20110263484A1 (en) 2008-10-13 2011-10-27 Zymogenetics, Inc. Single chain fc type iii interferons and methods of using same

Also Published As

Publication number Publication date
ES2311253T3 (es) 2009-02-01
DE60135393D1 (de) 2008-09-25
US20050106682A1 (en) 2005-05-19
RU2292394C2 (ru) 2007-01-27
BR0112119A (pt) 2003-05-06
US7655223B2 (en) 2010-02-02
DK1294888T3 (da) 2007-08-20
DE60128093T2 (de) 2007-12-27
CA2413258A1 (en) 2002-01-10
US7445913B2 (en) 2008-11-04
US20070049736A1 (en) 2007-03-01
US7252969B2 (en) 2007-08-07
EP1717316B1 (de) 2008-08-13
US7498154B2 (en) 2009-03-03
EP1294888B1 (de) 2007-04-25
DE60128093D1 (de) 2007-06-06
US20050014228A1 (en) 2005-01-20
US20070048841A1 (en) 2007-03-01
US20080102490A1 (en) 2008-05-01
EP1939293A2 (de) 2008-07-02
US20110054148A1 (en) 2011-03-03
AU2001271786A1 (en) 2002-01-14
US20120258458A1 (en) 2012-10-11
ES2286128T3 (es) 2007-12-01
US20040146988A1 (en) 2004-07-29
US20080214788A1 (en) 2008-09-04
US6927040B2 (en) 2005-08-09
CN100448993C (zh) 2009-01-07
US7241870B2 (en) 2007-07-10
JP2004502419A (ja) 2004-01-29
EP1294888A2 (de) 2003-03-26
US20020039763A1 (en) 2002-04-04
US20070042468A1 (en) 2007-02-22
WO2002002627A3 (en) 2003-01-03
US20090326204A1 (en) 2009-12-31
US20070043209A1 (en) 2007-02-22
US7919595B2 (en) 2011-04-05
US20110172170A1 (en) 2011-07-14
ATE404670T1 (de) 2008-08-15
JP4377126B2 (ja) 2009-12-02
US20090069274A1 (en) 2009-03-12
CN1443240A (zh) 2003-09-17
US7833520B2 (en) 2010-11-16
US20100222266A1 (en) 2010-09-02
US20120036590A1 (en) 2012-02-09
US20050106680A1 (en) 2005-05-19
EP1717316A1 (de) 2006-11-02
EP1939293A3 (de) 2008-07-09
WO2002002627A2 (en) 2002-01-10
EP2132984A3 (de) 2010-11-03
US7485700B2 (en) 2009-02-03
RU2003103099A (ru) 2005-01-20
DK1717316T3 (da) 2008-12-08
US7253261B2 (en) 2007-08-07
EP2132984A2 (de) 2009-12-16
CA2413258C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
DK1294888T3 (da) Interferonlignende protein Zcyto21
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ATE388963T1 (de) Homogene herstellungen von il-29
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
DK1003379T3 (da) Hidtil ukendt phytase
ATE170219T1 (de) Rekombinanter abkömmling des menschlichen faktors iii
UA84666C2 (ru) ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DE60228136D1 (de) Cytokin-proteinfamilie
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
NZ513549A (en) Malaria vaccine
DE60225699D1 (de) Nierenspezifischer urattransporter und dessen gen
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
MXPA04000397A (es) Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
EA200100440A1 (ru) Ген prv-1 и его применение
DE60021707D1 (de) Beta-primeverosidase gen
WO1999060117A3 (fr) Polypeptide prax-1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1294888

Country of ref document: EP